Interferon alfa

DB05258ApprovedInvestigationalWithdrawnProtein Based Therapies

Interferon alfa is an immunomodulator used to treat hepatitis B and C as well as certain types of cancer including cutaneous T-cell lymphoma and renal cell carcinoma. Natural interferon alpha or Multiferon is obtained from the leukocyte fraction of human blood following induction with Sendai virus.

Protein structure of Interferon alfa
Mechanism
Curator reviewed
Primary indication
Investigated for use/treatment in hepatitis (viral, C), leukemia (lymphoid), leukemia (myeloid), leukemia (unspecified), and melanoma.Curator reviewed · 6 structured indications
Formula / weight
20700.0 Da (range 19300-22100)
Also known as
alfa interferon · HuIFN-alpha-Le · IFN-α · Natural alpha interferon

Resolves to

What you can answer from here — as of April 16, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
689Drug interactionsStructured to mechanism, not free text
Sign in
195Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
12ContraindicationsEach with its own population and attribute set
Sign in
23Marketed productsAcross 2 countries and 7 labellers
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Interferon alfa, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account